EGFR Antibody
Duligotuzumab is a dual-targeting human IgG1 monoclonal antibody that simultaneously binds to both epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3) . Duligotuzumab exerts its antitumor effects by blocking these dual signaling pathways and by inducing antibody-dependent cellular cytotoxicity (ADCC), targeting tumors where EGFR/HER3 overexpression correlates with poor prognosis.
Product Specifications
Product Name Alternative
MEHD-7945A, Duligotumab, RG 7597
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Concentration
18.734 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
144.77 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ING1 sgRNA CRISPR Lentivector (Human) (Target 1)
Human Twisted Gastrulation Protein Homolog 1 (TWSG1) ELISA Kit